Pancreatic Cancer Research

ResearcherPeter MacCallum Cancer FoundationNo recent work listed

Fergal C. Kelleher

ORCID-verified (high confidence, 0.95), identity_conf@1As of 7 November 2026

Matched on ORCID iD 0000-0002-6717-6436; OpenAlex author ID A5077594856. Sources: OpenAlex.

Their work

Papers
4 (first author 1, last author 0)
Trials
0
Grants
0
Labs led
0
Collaborators
5
Papers, trials and grants by year

2011: 1 paper · 2012: 1 paper · 2013: none · 2014: none · 2015: none · 2016: none · 2017: 2 papers

Papers 4

  1. A novel inhibitory anti-invasive MAb isolated using phenotypic screening highlights AnxA6 as a functionally relevant target protein in pancreatic cancer. Co-author DOI 10.1038/bjc.2017.306↗
  2. Therapeutic Potential for FGFR Inhibitors in SOX9-FGFR2 Coexpressing Pancreatic Cancer. First author DOI 10.1097/mpa.0000000000000870↗
  3. Aberrations and therapeutics involving the developmental pathway Hedgehog in pancreatic cancer. Co-author DOI 10.1016/b978-0-12-394622-5.00016-x↗
  4. Hedgehog signaling and therapeutics in pancreatic cancer. Co-author DOI 10.1093/carcin/bgq280↗

Closest collaborators

The 5 strongest of 5 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.

  1. Ray McDermott · 2 shared papers, 2012–2017 · strength 0.14
  2. Hazel O’Sullivan · 1 shared paper, 2017 · strength 0.08
  3. Annemarie Larkin · 1 shared paper, 2017 · strength 0.06
  4. Dermot O'Sullivan · 1 shared paper, 2017 · strength 0.06
  5. Martin M. Clynes · 1 shared paper, 2017 · strength 0.06

How to reach this person

A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.